The drug changes the biology. But will it change the disease?
Looking back at semaglutide, our scores pointed the same way as its later outcome trials.
Our Co-founder and CSO Jakob Steinfeldt on why the first trials can tell us far earlier: pheiron.substack.com/p/engineering-…
Looking back at semaglutide, our scores pointed the same way as its later outcome trials.
Our Co-founder and CSO Jakob Steinfeldt on why the first trials can tell us far earlier: pheiron.substack.com/p/engineering-…